PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HER2- BC) Meeting Abstract
| Authors: | Gambardella, V.; Cervantes, A.; Bedard, P. L.; Hamilton, E. P.; Italiano, A.; Jhaveri, K.; Juric, D.; Kalinsky, K.; Krop, I. E.; Oliveira, M.; Saura, C.; Schmid, P.; Turner, N.; Varga, A.; Liu, B. P.; Chen, J. W.; Aimi, J.; Royer-Joo, S.; Schutzman, J. L.; Hutchinson, K. E. |
| Abstract Title: | PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HER2- BC) |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S381 |
| End Page: | S382 |
| Language: | English |
| ACCESSION: | WOS:000573469100336 |
| DOI: | 10.1016/j.annonc.2020.08.438 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 336P -- Source: Wos |
